|
1
|
Hu Q, Wei B, Wei L, Hua K, Yu X, Li H and
Ji H: Sodium tanshinone IIA sulfonate ameliorates ischemia-induced
myocardial inflammation and lipid accumulation in Beagle dogs
through NLRP3 inflammasome. Int J Cardiol. 196:183–192. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu L, Wei T, Gao J, Chang X, He H, Luo F,
Zhou R, Ma C, Liu Y and Yan T: The cardioprotective effect of
salidroside against myocardial ischemia reperfusion injury in rats
by inhibiting apoptosis and inflammation. Apoptosis. 20:1433–1443.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weinreuter M, Kreusser MM, Beckendorf J,
Schreiter FC, Leuschner F, Lehmann LH, Hofmann KP, Rostosky JS,
Diemert N, Xu C, et al: CaM Kinase II mediates maladaptive
post-infarct remodeling and pro-inflammatory chemoattractant
signaling but not acute myocardial ischemia/reperfusion injury.
EMBO Mol Med. 6:1231–1245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hua K, Sheng X, Li T, Wang LN, Zhang YH,
Huang ZJ and Ji H: The edaravone and 3-n-butylphthalide
ring-opening derivative 10b effectively attenuates cerebral
ischemia injury in rats. Acta Pharmacol Sin. 36:917–927. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fierro C, Novoa U, González V, Ocaranza MP
and Jalil JE: Simultaneous Rho kinase inhibition in circulating
leukocytes and in cardiovascular tissue in rats with high
angiotensin converting enzyme levels. Int J Cardiol. 215:309–317.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xue J, Fan B, Xing Q and Li T: Effect of
Y-27632 Rho-kinase inhibitor on proliferation and migration of
human glioblastoma cell. J Henan Univ Sci Technol. 28:247–252.
2010.
|
|
7
|
Ikeda F, Terajima H, Shimahara Y, Kondo T
and Yamaoka Y: Reduction of hepatic ischemia/reperfusion-induced
injury by a specific ROCK/Rho kinase inhibitor Y-27632. J Surg Res.
109:155–160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kan L, Smith A, Chen M, Ledford BT, Fan H,
Liu Z and He JQ: Rho-associated kinase inhibitor (Y-27632)
attenuates doxorubicin-induced apoptosis of human cardiac stem
cells. PLoS One. 10:e01445132015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong LY, Chen F, Xu M, Yao LP, Zhang YJ
and Zhuang Y: Quercetin attenuates myocardial ischemia-reperfusion
injury via downregulation of the HMGB1-TLR4-NF-kappaB signaling
pathway. Am J Transl Res. 10:1273–1283. 2018.
|
|
10
|
Bastien M, Poirier P, Lemieux I and
Després JP: Overview of epidemiology and contribution of obesity to
cardiovascular disease. Prog Cardiovasc Dis. 56:369–381. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gu D, Gupta A, Muntner P, Hu S, Duan X,
Chen J, Reynolds RF, Whelton PK and He J: Prevalence of
cardiovascular disease risk factor clustering among the adult
population of China: Results from the International Collaborative
Study of Cardiovascular Disease in Asia. Circulation. 112:658–665.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen T, Guo Q, Wang H, Zhang H, Wang C,
Zhang P, Meng S, Li Y, Ji H and Yan T: Effects of esculetin on
lipopolysaccharide (LPS)-induced acute lung injury via regulation
of RhoA/Rho kinase/NF-small ka, CyrillicB pathways in vivo and in
vitro. Free Radic Res. 49:1459–1468. 2015. View Article : Google Scholar
|
|
13
|
Ohki S, Iizuka K, Ishikawa S, Kano M,
Dobashi K, Yoshii A, Shimizu Y, Mori M and Morishita Y: A highly
selective inhibitor of Rho-associated coiled-coil forming protein
kinase, Y-27632, prolongs cardiac allograft survival of the
BALB/c-to-C3H/He mouse model. J Heart Lung Transplantat.
20:956–963. 2001. View Article : Google Scholar
|
|
14
|
Li C, Gao Y, Tian J, Shen J, Xing Y and
Liu Z: Sophocarpine administration preserves myocardial function
from ischemia- reperfusion in rats via NF-κB inactivation. J
Ethnopharmacol. 135:620–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin J, Wang H, Li J, Wang Q, Zhang S, Feng
N, Fan R and Pei J: κ-Opioid receptor stimulation modulates
TLR4/NF-κB signaling in the rat heart subjected to
ischemia-reperfusion. Cytokine. 61:842–848. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Henkel T, Machleidt T, Alkalay I, Krönke
M, Benneriah Y and Baeuerle PA: Rapid proteolysis of IκB-α is
necessary for activation of transcription factor NF-κB. Nature.
365:182–185. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gaestel M: MAPK-activated protein kinases
(MKs): Novel insights and challenges. Front Cell Dev Biol.
3:882016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iliodromitis EK, Gaitanaki C, Lazou A,
Bofilis E, Karavolias GK, Beis I and Kremastinos DT: Dissociation
of stress-activated protein kinase (p38-MAPK and JNKs)
phosphorylation from the protective effect of preconditioning in
vivo. J Mol Cellular Cardiol. 34:1019–1028. 2002. View Article : Google Scholar
|
|
20
|
Wei Y, Xu M, Ren Y, Lu G, Xu Y, Song Y and
Ji H: The cardioprotection of dihydrotanshinone I against
myocardial ischemia-reperfusion injury via inhibition of
arachidonic acid ω-hydroxylase. Can J Physiol Pharmacol.
94:1267–1275. 2016. View Article : Google Scholar : PubMed/NCBI
|
